Sage Journals: Discover world-class research

Retricted access

Review article

First published 2016-1

Daclatasvir

Michael A. Smith, Randolph E. Regal, Rima A. Mohammad

Annals of Pharmacotherapy

Free access

Research article

First published 2020-2

Pharmacokinetics of Daclatasvir in Egyptian Adolescents with Genotype-4 HCV Infection

Mogeb M Al-Nahari, Maggie M Abbassi, Fatma SE Ebeid [...]

Antiviral Therapy

Free access

Research article

First published 2014-7

A Randomized Trial of Daclatasvir with Peginterferon Alfa-2B and Ribavirin for HCV Genotype 1 Infection

Fumitaka Suzuki, Joji Toyota, Kenji Ikeda [...]

Antiviral Therapy

Free access

Research article

First published 2014-7

Effect of the Coadministration of Daclatasvir on the Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate

Marc Bifano, Heather Sevinsky, Carey Hwang [...]

Antiviral Therapy

Free access

Research article

First published 2014-7

Daclatasvir Combined with Peginterferon Alfa-2A and Ribavirin in Japanese Patients Infected with Hepatitis C Genotype 1

Namiki Izumi, Osamu Yokosuka, Norifumi Kawada [...]

Antiviral Therapy

Free access

Research article

First published 2016-5

Combination Therapies with Daclatasvir and Asunaprevir on NS3-D168 Mutated HCV in Human Hepatocyte Chimeric Mice

Hiromi Kan, Nobuhiko Hiraga, Michio Imamura [...]

Antiviral Therapy

Free access

Research article

First published 2013-10

Assessment of Pharmacokinetic Interactions of the HCV Ns5A Replication Complex Inhibitor Daclatasvir with Antiretroviral Agents: Ritonavir-Boosted Atazanavir,Efavirenz and Tenofovir

Marc Bifano, Carey Hwang, Berend Oosterhuis [...]

Antiviral Therapy

Free access

Announcement

First published 2012-7

Prevalence of Natural Polymorphisms at the HCV Ns5A Gene Associated with Resistance to Daclatasvir,An Ns5A Inhibitor

Zulema Plaza, Vincent Soriano, Eugenia Vispo [...]

Antiviral Therapy

Free access

Research article

First published 2019-1

Daclatasvir and Sofosbuvir with Ribavirin for 24 Weeks in Chronic Hepatitis C Genotype-3-Infected Patients with Cirrhosis: A Phase III Study (ALLY-3C)

Fred Poordad, Mitchell L Shiffman, Wayne Ghesquiere [...]

Antiviral Therapy

Free access

Research article

First published 2015-7

Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects with Renal Function Impairment

Tushar Garimella, Reena Wang, Wen-Lin Luo [...]

Antiviral Therapy

Search results